Metformin Ameliorates Diabetic Cardiomyopathy by Activating the PK2/PKR Pathway
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin Ameliorates Diabetic Cardiomyopathy by Activating the PK2/PKR Pathway
Authors
Keywords
-
Journal
Frontiers in Physiology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-05-19
DOI
10.3389/fphys.2020.00425
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic syndrome diminishes insulin-induced Akt activation and causes a redistribution of Akt-interacting proteins in cardiomyocytes
- (2020) Huguet V. Landa-Galvan et al. PLoS One
- Prokineticin 2 relieves hypoxia/reoxygenation-induced injury through activation of Akt/mTOR pathway in H9c2 cardiomyocytes
- (2020) Gang Su et al. Artificial Cells Nanomedicine and Biotechnology
- Phosphoinositide 3-kinase therapy in diabetic cardiomyopathy: unravelling an enigma
- (2020) Yaguang Bi et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Evaluation of myocardial fibrosis in diabetes with cardiac magnetic resonance T1-mapping: Correlation with the high-level hemoglobin A1c
- (2019) Yue Gao et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Combination of metformin and p38 MAPK inhibitor, SB203580, reduced myocardial ischemia/reperfusion injury in non‑obese type 2 diabetic Goto‑Kakizaki rats
- (2019) Jantira Sanit et al. Experimental and Therapeutic Medicine
- Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
- (2019) Marc Foretz et al. Nature Reviews Endocrinology
- Metformin Ameliorates Testicular Damage in Male Mice with Streptozotocin-Induced Type 1 Diabetes through the PK2/PKR Pathway
- (2019) Yuning Liu et al. Oxidative Medicine and Cellular Longevity
- Hyperglycemia induced testicular damage in type 2 diabetes mellitus rats exhibiting microcirculation impairments associated with vascular endothelial growth factor decreased via PI3K/Akt pathway
- (2018) Lingli Long et al. Oncotarget
- Prokineticin-2 promotes chemotaxis and alternative A2 reactivity of astrocytes
- (2018) Matthew Neal et al. GLIA
- Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis
- (2016) Hong Xu et al. JOURNAL OF ENDOCRINOLOGY
- Insulin-like growth factor-1 improves diabetic cardiomyopathy through antioxidative and anti-inflammatory processes along with modulation of Akt/GSK-3β signaling in rats
- (2016) Cheng Yu Wang et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Prokineticin-2 is associated with metabolic syndrome in a middle-aged and elderly Chinese population
- (2016) Yong Wang et al. Lipids in Health and Disease
- Trigonella foenum-graecumSeed Extract, 4-Hydroxyisoleucine, and Metformin Stimulate Proximal Insulin Signaling and Increase Expression of Glycogenic Enzymes and GLUT2 in HepG2 Cells
- (2016) Nikita Naicker et al. Metabolic Syndrome and Related Disorders
- (−)-Epicatechin induces physiological cardiac growth by activation of the PI3K/Akt pathway in mice
- (2016) Sergio De los Santos et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration
- (2016) Richard Gordon et al. Nature Communications
- Prokineticin receptor-1 signaling promotes Epicardial to Mesenchymal Transition during heart development
- (2016) Himanshu Arora et al. Scientific Reports
- Curcumin Protects Neonatal Rat Cardiomyocytes against High Glucose-Induced Apoptosis via PI3K/Akt Signalling Pathway
- (2016) Wei Yu et al. Journal of Diabetes Research
- Glucagon-like peptide 1 receptor agonist (GLP-1 RA): long-term effect on kidney function in patients with type 2 diabetes
- (2015) Bernt Johan von Scholten et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Prokineticin 2 (PROK2) is an important factor for angiogenesis in colorectal cancer
- (2015) Hidetaka Kurebayashi et al. Oncotarget
- Discovery and Cardioprotective Effects of the First Non-Peptide Agonists of the G Protein-Coupled Prokineticin Receptor-1
- (2015) Adeline Gasser et al. PLoS One
- Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals
- (2014) D Maftei et al. BRITISH JOURNAL OF PHARMACOLOGY
- G-protein-coupled Receptor Agonist BV8/Prokineticin-2 and STAT3 Protein Form a Feed-forward Loop in Both Normal and Malignant Myeloid Cells
- (2013) Hong Xin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A PK2/Bv8/PROK2 Antagonist Suppresses Tumorigenic Processes by Inhibiting Angiogenesis in Glioma and Blocking Myeloid Cell Infiltration in Pancreatic Cancer
- (2013) Valerie F. Curtis et al. PLoS One
- Prokineticin Receptor‐1 Is a New Regulator of Endothelial Insulin Uptake and Capillary Formation to Control Insulin Sensitivity and Cardiovascular and Kidney Functions
- (2013) Mojdeh Dormishian et al. Journal of the American Heart Association
- Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function
- (2012) Yingmei Zhang et al. BMC Medicine
- Genetic Inactivation of Prokineticin Receptor-1 Leads to Heart and Kidney Disorders
- (2011) Mounia Boulberdaa et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Prokineticin receptor 1 (PKR1) signalling in cardiovascular and kidney functions
- (2011) M. Boulberdaa et al. CARDIOVASCULAR RESEARCH
- The Role of the Prokineticin 2 Pathway in Human Reproduction: Evidence from the Study of Human and Murine Gene Mutations
- (2011) Cecilia Martin et al. ENDOCRINE REVIEWS
- Prokineticin 2 Is a Hypothalamic Neuropeptide That Potently Inhibits Food Intake
- (2009) J. V. Gardiner et al. DIABETES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started